Confirma breast MRI CAD provider for RadNet Management

TriMed Staff | | Health Imaging | Breast MRI
Confirma Inc. will provide its CADstream system to RadNet Management Inc., a California provider of medical imaging services, making it the exclusive breast MRI (magnetic resonance imaging) CAD (computer aided detection) system for RadNet's 55 diagnostic imaging centers.

RadNet previously bought two CADstream systems and the agreement includes an additional sale and installation of two more CADstream systems with the option to buy additional systems as the number of RadNet sites increases.

CADstream's automated features include image registration, subtractions, angiogenesis maps, interactive real-time contrast curves, multiplanar reformatting, maximum intensity projections (MIPs), volume summaries and the SureLoc interventional guidance tool.

TriMed Staff

Related Content

AI model spots up to 30% of breast cancers missed on MRI
Breast cancer only visible via MRI is often less aggressive
The pros and cons of current breast screening modalities and the role of AI
AI tool's supplemental MRI recs help detect 4 times more breast cancers than density measures
Applying Node-RADS to breast MRI exams improves staging
New study results 'strongly' back supplemental MRI for women with dense breasts

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.